Unrelated donor bone marrow transplantation for thalassemia: The effect of extended haplotypes

Blood

Volumn 99, Issue 12, 2002, Pages 4350-4356

  La Nasa, Giorgio ^a,b,c,d   Giardini, Claudio ^a,b,c,d   Argiolu, Francesca ^a,b,c,d   Locatelli, Franco ^a,b,c,d   Arras, Marcella ^a,b,c,d   De Stefano, Piero ^a,b,c,d   Ledda, Antonio ^a,b,c,d   Pizzati, Antonella ^a,b,c,d   Sanna, Maria A ^a,b,c,d   Vacca, Adriana ^a,b,c,d   Lucarelli, Guido ^a,b,c,d   Contu, Licinio ^a,b,c,d  

^a Binaghi Hospital   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c SAN SALVATORE HOSPITAL   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DONOR; FEMALE; GENE SEGREGATION; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MALE; MORTALITY; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

EID: 0037097807     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.12.4350     Document Type: Article

References (55)

1. Bone marrow transplantation for beta-thalassemia
2. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy
3. Marrow transplantation for patients with thalassemia: Results in class 3 patients
4. Marrow transplantation from unrelated volunteer donors
5. The β-thalassemia
6. Genetic modifying factors in betathalassemia
7. Iron-chelating therapy and the treatment of thalassemia
8. Survival and causes of death in thalassemia major
9. Survival in medically treated patients with homozygous beta-thalassemia
10. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program
11. Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies
12. Unrelated donor bone marrow transplantation for Fanconi anemia
13. Frequent HLA class I and DP sequence mismatchs in serologically (HLA-A, HLA-B, HLA-DR) and molecularly (HLA- DRB1, HLA-DQA1, HLA-DQB1) HLA-identical unrelated bone marrow transplant pairs
14. Effect of HLA incompatibility in marrow transplantation for patients from unrelated donors and mismatched related donors
15. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors
16. Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow transplantation in children with leukaemia
17. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukaemia
18. Engraftment and survival after unrelated-donor bone marrow transplantation: A report from the National Marrow Donor Program
19. High resolution HLA typing associated with decreased mortality after unrelated bone marrow transplantation
20. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient
21. Updated characterization of the ancestral haplotypes using the fourth Asia-Oceania Histocompatibility Workshop panel
22. Questions in marrow matching: The implications of ancestral haplotypes for routine practice
23. Matching for MHC haplotypes results in improved survival following unrelated bone marrow transplantation
24. Role of HLA extended haplotypes in unrelated bone marrow transplantation
25. Bone marrow transplantation in thalassemia
26. Reversal features of hepatic haemosiderosis and haemochromatosis in thalassemia after bone marrow transplantation
27. A generic sequencing based typing approach for the identification of HLA-A diversity
28. HLA-B locus sequence-based typing
29. A reliable and efficient high resolution typing method for HLA-C using sequence-based typing
30. Comparison of DRB sequence-based typing using different strategies
31. Nomenclature for factors of the HLA system, 1998
32. Inherited structural polymorphism of the fourth component of human complement
33. Genetic polymorphism in human glycine-rich-beta lipoprotein
34. Genomics of the major histocompatibility complex: Haplotypes, duplication, retrovires and disease
35. HLA polymorphisms in Italian bone marrow donors: A regional analysis
36. HLA structure of the Sardinian population: A haplotype study of 551 families
37. Characterisation of 4OHW cell line panel including data for the 10 IHW panel
38. Allele and haplotype frequences for HLA and complement loci in various ethnic groups
39. Estimation of HLA-A-B-DR haplotype frequencies in five racial groups represented in the NMDP donor file
40. Bone marrow transplantation
41. Chronic graft-versus-host syndrome in man: A long-term clinico-pathologic study of 20 Seattle patients
42. Non parametric estimation from incomplete observations
43. Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants
44. Successful unrelated bone marrow transplantation in thalassemia
45. Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia
46. Resolution of immune hemolytic anemia with allogeneic bone marrow transplantation after an unsuccessful autograft
47. Bone marrow transplantation in thalassemia
48. MHC haplotypes including eight microsatellites in French Basques and in Sardinian
49. Unrelated individuals matched for MHC extended haplotypes and HLA identical siblings shows comparable responses in MLC
50. Anthropology: Contribution of HLA
51. Hla-Dp and allogeneic bone marrow transplantation
52. The biological significance of HLA-DP gene variation in haematopoietic cell transplantation
53. Graft rejection and toxicity following bone marrow transplantation in relation to Busulphan pharmacokinetics
54. Marrow transplantation for thalassemia following busulphan and cyclophosphamide
55. TBI, thiotepa and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukaemia in 1st or 2nd remission given bone marrow transplantation from HLA-identical siblings